Clinical Trials Logo

Functional Constipation clinical trials

View clinical trials related to Functional Constipation.

Filter by:

NCT ID: NCT03391635 Completed - Clinical trials for Functional Constipation

Efficacy of Electroacupuncture Compared With Transcutaneous Electric Nerve Stimulation for Functional Constipation

Start date: July 1, 2018
Phase: N/A
Study type: Interventional

The objective of this trial is to compare the efficacy of electroacupuncture versus transcutaneous electric nerve stimulation for functional constipation

NCT ID: NCT03333070 Terminated - Clinical trials for Functional Constipation

The Use of Lactobacillus Reuteri in Functional Constipation in Children

Start date: June 26, 2018
Phase: N/A
Study type: Interventional

Functional constipation (FC) is a common condition in childhood, with an estimated prevalence of 0.7% to 29%.The diagnosis and treatment of FC can be difficult tasks, and children are often referred to specialist services causing treatment to become expensive and time-consuming.The standard treatment based on osmotic laxatives (mainly PEG). The recovery rate is 50% to 60% after 1 year of treatment, with 50% of the children having relapse within 5 years. Studies in adults have established the effectiveness of some lactic acid bacteria in the treatment of chronic constipation.

NCT ID: NCT03054805 Completed - Clinical trials for Functional Constipation

The Effect of Probiotics on Constipation, and Intestinal Microflora in Children With Functional Constipation

Start date: September 2014
Phase: Phase 4
Study type: Interventional

To compare the differences of fecal microflora between constipated and non-constipated healthy children, and evaluate the efficacy of probiotics in reducing symptoms of constipation and the influence of intestinal microflora in children with functional constipation.

NCT ID: NCT02854098 Recruiting - Clinical trials for Functional Constipation

The Comorbidity of Benign Hypermobility Joint Syndrome and Functional Constipation in Children

MobCon
Start date: April 2015
Phase: N/A
Study type: Observational [Patient Registry]

Benign Hypermobility Joint Syndrome is a group of inherited abnormalities in the structure of connective tissues, manifested by disturbances in the proportion of collagen. The main symptoms of this syndrome include: laxity of joint capsules and ligaments, hypermobility of the joints, as well as numerous disturbances in the functioning of internal organs that contain connective tissue, including the gastrointestinal tract. Hypermobility of joints affects approximately 10% of the population of Western countries, is more common in small children and female. Modified Beighton scale is the basic scale for assessing hypermobility of joints. The scale (as assessed using the goniometer) is a reliable tool for the evaluation of excessive laxity of the connective tissue in children. Functional constipation is a very common condition, affecting approximately 3-5% of children and adolescents, with peak onset between 2 and 4 years of age. The etiology of this disorder is multifactorial, and till day it is still exactly unknown why some children develop constipation, while in others we can observe the correct scheme of defecation. Suspending stool enhances the retention of fecal masses, which subsequently causes painful defecation. Diagnosis is based on history, clinical symptoms and physical examination. Increased susceptibility of the wall of the distal gastrointestinal tract could explain the predisposition of some children to retain fecal masses and the development of constipation. Due to the unclear etiology of functional constipation, it seems reasonable to conduct a study assessing whether excessive laxity of connective tissue (assessed on the basis of the hypermobility of the joints) facilitates the accumulation of stool in the large intestine, and so is the one of the reasons leading to development of functional constipation in children.

NCT ID: NCT02649062 Completed - Clinical trials for Functional Constipation

Study of NGM282 in Subjects With Functional Constipation and Healthy Individuals

Start date: December 2015
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this study is to determine the effect of NGM282 on colonic transit, bile acid homeostasis, and fecal fat in subjects with functional constipation and healthy individuals.

NCT ID: NCT02592200 Completed - Clinical trials for Functional Constipation

Effect of Lactobacillus Gasseri DSM 27123 on Functional Constipation in Healthy Women

Start date: October 5, 2015
Phase: N/A
Study type: Interventional

The primary objective is to determine the change in frequency of complete spontaneous bowel movements (CSBMs) after 4 weeks of oral supplementation with Lactobacillus gasseri DSM 27123 in healthy adult women with functional constipation.

NCT ID: NCT02538367 Completed - Clinical trials for Functional Constipation

Phase 1/2a Trial of YH12852 in Healthy Subjects and Patients With Functional Constipation

Start date: August 2015
Phase: Phase 1/Phase 2
Study type: Interventional

A randomized, double-blind/open-label, placebo/active-controlled, single/multiple dose, parallel, phase 1/2a trial to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of YH12852 in healthy subjects and patients with functional constipation

NCT ID: NCT02418507 Completed - Clinical trials for Functional Constipation

An Evaluation of the Effectiveness of a Proprietary Probiotic Blend on Functional Constipation

Start date: May 29, 2015
Phase: Phase 2
Study type: Interventional

The primary objective for this study is to monitor the change in patient assessed symptoms of constipation in subjects taking the proprietary probiotic blend compared to those taking the placebo. The secondary objective for this study is to additionally monitor changes in stool consistency, stool frequency, quality of life and microbial composition of feces from baseline to Day 29, in all subjects. Safety considerations monitored any changes in blood safety parameters as well as incidence of adverse events throughout the entire study for all subjects.

NCT ID: NCT02361749 Active, not recruiting - Clinical trials for Functional Constipation

Botulinum Toxin Injection Versus Anal Myectomy in Management of Idiopathic Constipation

Start date: September 2014
Phase: Phase 4
Study type: Interventional

Chronic idiopathic constipation is most common cause of Constipation in childhood with numerous cases in Egypt. Numerous conservative measures were tried but many fail. Surgical options include Longitudinal Myectomy of the muscle or injection of Botulinum toxin. Objectives: Comparative study between Botulinum toxin injection and Myectomy in treatment of Idiopathic Constipation

NCT ID: NCT02359396 Completed - Clinical trials for Functional Constipation

A Randomized, Open-label, Three-arm Study of MZRW on Tolerability, Exposure and Pharmacokinetics

Start date: November 2014
Phase: Phase 1
Study type: Interventional

This is a randomized open-label, three-arm, phase 1 clinical study. The investigators aim to investigate a Chinese Proprietary Medicine, MZRW on its tolerability, system exposure and pharmacokinetics profile.